CN Stock MarketDetailed Quotes

605116 Aurisco Pharmaceutical

Watchlist
  • 21.96
  • +0.88+4.17%
Trading Jun 20 10:12 CST
8.92BMarket Cap27.38P/E (TTM)

Aurisco Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aurisco Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 29, 2024

Revenue(YoY)

335.62M

+11.08%
EPS(YoY)

0.20

+81.82%
Analyst Rating

Strong Buy

Jun 19, 2024

Aurisco Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.144B--
--2024/FY-- / 1.677B--
--2023/FY1.263B / 1.322B--
--2022/FY1.008B / 1.056B--
--2021/FY803.363M / 819.000M--
--2020/FY721.440M / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.144B--
--2024/FY-- / 1.677B--
--2023/FY1.263B / 1.322B--
--2022/FY1.008B / 1.056B--
--2021/FY803.363M / 819.000M--
--2020/FY721.440M / ----
--------
--------
--------
--------

Unlock Free Earnings Estimates

Aurisco Pharmaceutical Earnings Reports

  • Summary of the 2023 Annual Report of Orient Pharmaceutical Co., Ltd.

    Apr 29 00:00

  • Orient Pharmaceutical Co., Ltd. 2023 Annual Report

    Apr 29 00:00

  • Orient Pharmaceutical Co., Ltd. 2024 First Quarter Report

    Apr 29 00:00

  • Orient Pharmaceutical Co., Ltd. 2023 Third Quarter Report

    Oct 31, 2023 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 19, 2024

    Strong Buy

    • Strong Buy

      60.00%

    • Buy

      40.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg